V8 Peptides — Engineered Performance
Tirzepatide — 30 mg
≥98% PURITY✓ SEQUENCE VERIFIED✓ VIEW COA (LOT ARC-TZ30-002)

Tirzepatide

Dual GIP / GLP-1 receptor agonist

$190.00

Secure payment by card link, Zelle or crypto · discreet packaging · fast USPS shipping

Dual GLP-1 and GIP receptor agonist engineered for advanced metabolic and lipid research. Supplied as a lyophilized powder with ≥98% HPLC purity verification.

Research applications

  • 01Incretin (GIP / GLP-1) receptor signaling
  • 02Glucose-regulation research models
  • 03Energy-expenditure & lipid-metabolism studies
Sizes
30 mg
Purity
≥98%
Molecular formula
C225H348N48O68
Sequence / identity
Provided on batch COA
Supplied form
Lyophilized powder
Storage
Refrigerate at 2–8 °C; −20 °C for long-term. Protect from heat, moisture & light.
Container
Sealed clear glass research vial
≥98%
Measured purity (HPLC)
✓ Batch-specific COA published on our siteView this lot's COA →How we test →
  • ✓Compound identity & sequence
  • ✓Measured purity (HPLC %)
  • ✓Sequence / identity confirmation
  • ✓Batch / lot number
  • ✓Analytical test date
  • ✓Supplied form & storage

Research Use Only. All products are sold strictly for laboratory research and development purposes only. Not for human or animal consumption. Not a drug, food, or cosmetic. By purchasing, you affirm you are a qualified researcher or institution.

Batch documentation

Batch-specific analytical documentation supports receiving, verification, and internal recordkeeping.

Storage guidance

Refrigerate the supplied material, freeze for long-term storage, and protect it from heat, moisture, and light.

Research-only labeling

Every vial is clearly identified for laboratory research use only — not for human or veterinary use.

What Is Tirzepatide?

Tirzepatide (LY3298176) is a 39-residue synthetic peptide built on the native GIP sequence and engineered to engage two incretin receptors: the GIP receptor and the GLP-1 receptor. Because one molecule drives both pathways, it is often described in the literature as a dual agonist, and it has become a standard tool compound for laboratories that study incretin receptor signaling, biased agonism and glucose-regulation models.

The molecule (molecular formula C225H348N48O68) carries a C20 fatty diacid attached through a linker at a lysine side chain. This lipidation promotes albumin binding and is a well-characterized example of half-life engineering, which is why tirzepatide also turns up in formulation, stability and analytical-chemistry projects. In the lab it is used for receptor-binding experiments, cAMP accumulation assays, comparison against single-receptor GLP-1 agonists, and as a reference standard during method development. V8 Peptides supplies it as a 30 mg lyophilized vial.

Tirzepatide Specifications

CompoundTirzepatide (LY3298176)
Vial size30 mg
Purity≥98% by HPLC
Molecular formulaC225H348N48O68
ClassDual GIP / GLP-1 receptor agonist
FormLyophilized powder, sealed clear glass vial
Storage2–8 °C short term; −20 °C long term

Reconstitution & Storage for Research

A 30 mg vial holds more peptide than most single-compound vials, so the diluent volume you choose has a large effect on the working concentration. Decide on the stock strength your assay needs first, then work backward to the volume.

Concentration math

  • Adding 3 mL of diluent to a 30 mg vial gives 10 mg/mL.
  • Adding 2 mL of diluent to a 30 mg vial gives 15 mg/mL.
  • Adding 1.5 mL of diluent to a 30 mg vial gives 20 mg/mL.
  • Diluting 0.1 mL of a 10 mg/mL stock into 0.9 mL of buffer gives a 1 mg/mL working solution.

The V8 calculator handles these conversions for any volume, and the calculator guide explains each input. When adding diluent, direct the stream against the glass instead of onto the lyophilized cake, then roll or swirl the vial until the solution is clear. Avoid vortexing.

Storage conditions

Store sealed vials in the refrigerator at 2–8 °C, or move them to a −20 °C freezer for long-term holding. Heat, moisture and light all accelerate peptide degradation, so keep vials in their box and away from the freezer door. After reconstitution, keep the solution at 2–8 °C and aliquot it to limit freeze-thaw exposure. More detail is in our tirzepatide storage and stability article.

Quality & Testing

Purity claims are only useful when a lab can check them. Each tirzepatide batch is tested by HPLC against a ≥98% release specification, and the resulting certificate of analysis is tied to the lot number on the vial label.

  • Measured HPLC purity for that batch
  • Compound identity and sequence confirmation
  • Lot number and date of analysis
  • Form and recommended storage

You can open the current certificate from the COA library at any time. For background on how the analysis is run and how to read the report, see tirzepatide purity testing.

Related Lab Guides

For laboratory research use only; not for human consumption.

Frequently Asked Questions

What purity is Tirzepatide?+

Tirzepatide is verified to ≥98% purity by HPLC, with identity confirmed by batch-specific analytical documentation (COA) published on our site.

How is Tirzepatide supplied and stored?+

Tirzepatide is supplied as a lyophilized powder. Refrigerate at 2–8 °C, or freeze at −20 °C for long-term storage. Protect from heat, moisture, and light.

Do you provide a Certificate of Analysis?+

Yes — every batch ships with batch-specific analytical documentation (COA) to support qualified receiving and internal recordkeeping.

Is Tirzepatide approved for human use?+

No. This product is sold strictly for laboratory research and development purposes and is not for human or animal consumption.